Bone Biologics Corp (BBLG) Stock Price, Quote & News - Mboum

Company Profile

Bone Biologics Corporation, a medical device company, focuses on bone regeneration in spinal fusion using the recombinant human protein in the United States. Its lead product is NELL-1/DBM medical device, an osteopromotive recombinant protein, which provides target specific control over bone regeneration. The company also develops NB1, a NELL-1/DBM fusion device for use in lumbar spinal fusion, as well as spine implants, non-union trauma cases, and osteoporosis applications. It serves spine surg...

Industry: Biotechnology

Sector: Healthcare

Phone: 781 552 4452

Website: www.bonebiologics.com

Address:

2 Burlington Woods Drive, Suite 100, Burlington, United States

Kesiya Jun. 18 at 8:01 AM

$BBLG Buy now']

0 · Reply

Harold_the_Hedge Jun. 17 at 7:31 PM

$BBLG wen rs

0 · Reply

l33c14rky Jun. 17 at 10:11 AM

$BBLG round zwei 🥳

0 · Reply

ClassiTrader Jun. 17 at 8:40 AM

$BBLG 👀 1.60

0 · Reply

terrapin22 Jun. 17 at 6:21 AM

$BBLG still here waiting patiently

0 · Reply

tarzzanman Jun. 12 at 8:11 PM

$BBLG Trash 😂

0 · Reply

TheUnmaker Jun. 1 at 4:24 PM

$TNXP $HSCS $CCCC $BBLG

0 · Reply

TheUnmaker May. 29 at 11:45 AM

$TNXP Super strong this morning.. setting up for a run! $CCCC $SLS $QSI $BBLG

1 · Reply

TheUnmaker May. 28 at 9:35 PM

$TNXP Great hold on the 1H 55 EMA today.. strong support above the 15m 200 EMA as well. Shorts tried to kill it several times under $12.65 but they were very unsuccessful. We've all see how this eagle flies when her wings are clipped. Our time to shine is coming soon. $QSI $CCCC $SLS $BBLG

1 · Reply

TheUnmaker May. 28 at 5:11 PM

$TNXP We look ready for next leg up. $CCCC $SLS $BBLG $GALT

0 · Reply

Latest News on BBLG

Bone Biologics achieves 29-month shelf life for rhNELL-1

2026-05-19T12:10:05.000Z - 5 weeks ago

Bone Biologics achieves 29-month shelf life for rhNELL-1

Bone Biologics Achieves 29-Month Validated Shelf Life for rhNELL-1

May 19, 2026, 8:00 AM EDT - 5 weeks ago

Bone Biologics Achieves 29-Month Validated Shelf Life for rhNELL-1

Bone Biologics summarizes key milestones achieved during 2025

2026-01-08T13:40:29.000Z - 5 months ago

Bone Biologics summarizes key milestones achieved during 2025

Bone Biologics Highlights 2025 Key Operational, Scientific, and Corporate Milestones and Provides 2026 Outlook

Jan 8, 2026, 8:00 AM EST - 5 months ago

Bone Biologics Highlights 2025 Key Operational, Scientific, and Corporate Milestones and Provides 2026 Outlook

Bone Biologics receives confirmation rhNELL-1 shelf life extended to 24 months

2025-12-23T13:05:40.000Z - 6 months ago

Bone Biologics receives confirmation rhNELL-1 shelf life extended to 24 months

Bone Biologics Improves Extension of rhNELL-1 Product Shelf Life to 24 Months

Dec 23, 2025, 8:00 AM EST - 6 months ago

Bone Biologics Improves Extension of rhNELL-1 Product Shelf Life to 24 Months

Bone Biologics CEO Issues Letter to Stockholders Highlighting Company Update and Outlook

Sep 4, 2025, 7:00 AM EDT - 10 months ago

Bone Biologics CEO Issues Letter to Stockholders Highlighting Company Update and Outlook

Bone Biologics to Participate in the H.C. Wainwright Global Investment Conference

Sep 3, 2025, 7:00 AM EDT - 10 months ago

Bone Biologics to Participate in the H.C. Wainwright Global Investment Conference

Bone Biologics Announces Closing of $5.0 Million Public Offering

Jun 30, 2025, 4:10 PM EDT - 1 year ago

Bone Biologics Announces Closing of $5.0 Million Public Offering

Bone Biologics Announces Pricing of $5.0 Million Public Offering

Jun 27, 2025, 9:10 AM EDT - 1 year ago

Bone Biologics Announces Pricing of $5.0 Million Public Offering

Why Is Bone Biologics Stock (BBLG) Up 100% Today?

2025-06-27T12:25:15.000Z - 1 year ago

Why Is Bone Biologics Stock (BBLG) Up 100% Today?

Bone Biologics files NELL-1 protein patent application with USPTO

2025-06-27T11:15:19.000Z - 1 year ago

Bone Biologics files NELL-1 protein patent application with USPTO

Bone Biologics Files Patent Application for Bone Regeneration Technology

Jun 27, 2025, 7:00 AM EDT - 1 year ago

Bone Biologics Files Patent Application for Bone Regeneration Technology

Bone Biologics regains compliance with Nasdaq listing

2025-06-26T20:25:38.000Z - 1 year ago

Bone Biologics regains compliance with Nasdaq listing

Bone Biologics Regains Compliance with Nasdaq Continued Listing Requirements

Jun 26, 2025, 4:20 PM EDT - 1 year ago

Bone Biologics Regains Compliance with Nasdaq Continued Listing Requirements

Bone Biologics files $35M mixed securities shelf

2025-06-24T21:05:27.000Z - 1 year ago

Bone Biologics files $35M mixed securities shelf

Bone Biologics Corp trading halted, news pending

2025-06-09T23:50:10.000Z - 1 year ago

Bone Biologics Corp trading halted, news pending

Bone Biologics announces 1-for-6 reverse stock split

2025-06-06T12:15:30.000Z - 1 year ago

Bone Biologics announces 1-for-6 reverse stock split

Bone Biologics Announces 1-for-6 Reverse Stock Split

Jun 6, 2025, 8:00 AM EDT - 1 year ago

Bone Biologics Announces 1-for-6 Reverse Stock Split

Bone Biologics Appoints Phillip T. Meikle to its Board of Directors

Oct 21, 2024, 8:00 AM EDT - 1 year ago

Bone Biologics Appoints Phillip T. Meikle to its Board of Directors

Bone Biologics Corporation to Present at the H.C. Wainwright 26th Annual Global Investment Conference

Sep 4, 2024, 8:00 AM EDT - 1 year ago

Bone Biologics Corporation to Present at the H.C. Wainwright 26th Annual Global Investment Conference

Bone Biologics files to sell 1.62M shares of common stock for holders

2024-08-12T21:02:54.000Z - 2 years ago

Bone Biologics files to sell 1.62M shares of common stock for holders

Bone Biologics Announces Exercise of Warrants for $2.1 Million Gross Proceeds

Aug 2, 2024, 8:00 AM EDT - 2 years ago

Bone Biologics Announces Exercise of Warrants for $2.1 Million Gross Proceeds

Bone Biologics treated first two patients in study of NB1 bone graft device

2024-06-20T12:11:52.000Z - 2 years ago

Bone Biologics treated first two patients in study of NB1 bone graft device

First Two Patients Treated in Pilot Clinical Study with Bone Biologics' NB1 Bone Graft Device in Spine Fusion

Jun 20, 2024, 8:00 AM EDT - 2 years ago

First Two Patients Treated in Pilot Clinical Study with Bone Biologics' NB1 Bone Graft Device in Spine Fusion

Bone Biologics Announces Closing of $2.0 Million Public Offering

Mar 6, 2024, 4:15 PM EST - 2 years ago

Bone Biologics Announces Closing of $2.0 Million Public Offering

Bone Biologics Announces Pricing of $2.0 Million Public Offering

Mar 4, 2024, 9:15 AM EST - 2 years ago

Bone Biologics Announces Pricing of $2.0 Million Public Offering

Bone Biologics reports progress with NB1 clinical program

2024-03-01T13:06:39.000Z - 2 years ago

Bone Biologics reports progress with NB1 clinical program

Bone Biologics Reports Progress With NB1 Clinical Program

Mar 1, 2024, 8:00 AM EST - 2 years ago

Bone Biologics Reports Progress With NB1 Clinical Program

Bone Biologics files to sell common stock, warrants, no amount given

2024-01-30T22:11:20.000Z - 2 years ago

Bone Biologics files to sell common stock, warrants, no amount given

Bone Biologics Appoints Healthcare Finance Veteran Robert E. Gagnon to Board of Directors

Jan 11, 2024, 8:00 AM EST - 2 years ago

Bone Biologics Appoints Healthcare Finance Veteran Robert E. Gagnon to Board of Directors

Bone Biologics regains compliance with Nasdaq continued listing rule

2024-01-10T13:03:43.000Z - 2 years ago

Bone Biologics regains compliance with Nasdaq continued listing rule

Bone Biologics files to sell 142,384 shares of common stock for holders

2024-01-05T22:18:07.000Z - 2 years ago

Bone Biologics files to sell 142,384 shares of common stock for holders

Bone Biologics files to sell 142K shares of common stock for holders

2024-01-05T22:18:03.000Z - 2 years ago

Bone Biologics files to sell 142K shares of common stock for holders

Bone Biologics Corp trading halted, news pending

2023-12-20T00:50:00.000Z - 2 years ago

Bone Biologics Corp trading halted, news pending

Bone Biologics announces 1-for-8 reverse stock split

2023-12-18T13:12:24.000Z - 2 years ago

Bone Biologics announces 1-for-8 reverse stock split

Bone Biologics Announces 1-for-8 Reverse Stock Split

Dec 18, 2023, 8:00 AM EST - 2 years ago

Bone Biologics Announces 1-for-8 Reverse Stock Split

Bone Biologics Announces Closing of Registered Direct Offering Priced At-the-Market Under Nasdaq Rules

Nov 20, 2023, 12:38 PM EST - 2 years ago

Bone Biologics Announces Closing of Registered Direct Offering Priced At-the-Market Under Nasdaq Rules

Bone Biologics Announces Registered Direct Offering Priced At-the-Market Under Nasdaq Rules

Nov 16, 2023, 4:43 PM EST - 2 years ago

Bone Biologics Announces Registered Direct Offering Priced At-the-Market Under Nasdaq Rules

Bone Biologics Provides Scientific Update on NB1 Bone Graft Device

Sep 26, 2023, 8:00 AM EDT - 2 years ago

Bone Biologics Provides Scientific Update on NB1 Bone Graft Device

Bone Biologics stock plummets more than 50% after stock offering prices at deep discount

Jun 15, 2023, 9:22 AM EDT - 3 years ago

Bone Biologics stock plummets more than 50% after stock offering prices at deep discount

Bone Biologics Prices $5.0 Million Underwritten Public Offering

Jun 14, 2023, 11:30 PM EDT - 3 years ago

Bone Biologics Prices $5.0 Million Underwritten Public Offering

Bone Biologics Effects 1-for-30 Reverse Stock Split

Jun 6, 2023, 1:00 PM EDT - 3 years ago

Bone Biologics Effects 1-for-30 Reverse Stock Split

Bone Biologics Receives Human Research Ethics Committee Approval to Begin Pilot Clinical Trial with NB1 in Spinal Fusion Patients in Australia

Apr 11, 2023, 8:00 AM EDT - 3 years ago

Bone Biologics Receives Human Research Ethics Committee Approval to Begin Pilot Clinical Trial with NB1 in Spinal Fusion Patients in Australia

Bone Biologics Advances Preparations for NB1 Pilot Clinical Trial with Engagement of Contract Research Organization

Jan 26, 2023, 8:30 AM EST - 3 years ago

Bone Biologics Advances Preparations for NB1 Pilot Clinical Trial with Engagement of Contract Research Organization

Bone Biologics CEO Issues Letter to Stockholders

Oct 25, 2022, 8:00 AM EDT - 3 years ago

Bone Biologics CEO Issues Letter to Stockholders

WallachBeth Capital Announces Closing of Bone Biologics $5,100,000 Underwritten Public Offering

Oct 13, 2022, 9:00 AM EDT - 4 years ago

WallachBeth Capital Announces Closing of Bone Biologics $5,100,000 Underwritten Public Offering

Bone Biologics Announces Closing of $5,100,000 Underwritten Public Offering

Oct 12, 2022, 4:05 PM EDT - 4 years ago

Bone Biologics Announces Closing of $5,100,000 Underwritten Public Offering

CORRECTING and REPLACING Bone Biologics Prices $5,100,000 Underwritten Public Offering

Oct 7, 2022, 10:52 AM EDT - 4 years ago

CORRECTING and REPLACING Bone Biologics Prices $5,100,000 Underwritten Public Offering

WallachBeth Capital Announces Pricing of Bone Biologics $5,100,000 Underwritten Public Offering

Oct 7, 2022, 10:16 AM EDT - 4 years ago

WallachBeth Capital Announces Pricing of Bone Biologics $5,100,000 Underwritten Public Offering

Bone Biologics Prices $5,100,000 Million Underwritten Public Offering

Oct 7, 2022, 8:00 AM EDT - 4 years ago

Bone Biologics Prices $5,100,000 Million Underwritten Public Offering

Bone Biologics to Participate in the 2022 Virtual Growth Conference Presented by Maxim Group LLC and Hosted by M-Vest

Mar 23, 2022, 8:00 AM EDT - 4 years ago

Bone Biologics to Participate in the 2022 Virtual Growth Conference Presented by Maxim Group LLC and Hosted by M-Vest

Bone Biologics Enters into Supply Agreement with MTF Biologics for Demineralized Bone Matrix

Mar 7, 2022, 7:00 AM EST - 4 years ago

Bone Biologics Enters into Supply Agreement with MTF Biologics for Demineralized Bone Matrix

Bone Biologics to Present at the H.C. Wainwright BioConnect Virtual Conference

Jan 5, 2022, 8:30 AM EST - 4 years ago

Bone Biologics to Present at the H.C. Wainwright BioConnect Virtual Conference

Bone Biologics Corp. Announces Closing of Public Offering and Uplisting to Nasdaq

Oct 18, 2021, 8:30 AM EDT - 5 years ago

Bone Biologics Corp. Announces Closing of Public Offering and Uplisting to Nasdaq

WallachBeth Capital Announces Completion of Bone Biologics Corp. (NASDAQ: BBLG) $7.9 million Public Offering

Oct 15, 2021, 12:00 PM EDT - 5 years ago

WallachBeth Capital Announces Completion of Bone Biologics Corp. (NASDAQ: BBLG) $7.9 million Public Offering

WallachBeth Capital announces pricing of Bone Biologics Corp. (NASDAQ: BBLG) $7.9 million Public Offering and Uplisting to the NASDAQ Capital Market

Oct 13, 2021, 1:43 PM EDT - 5 years ago

WallachBeth Capital announces pricing of Bone Biologics Corp. (NASDAQ: BBLG) $7.9 million Public Offering and Uplisting to the NASDAQ Capital Market

Bone Biologics Corp. Announces Pricing of $7.9 million Public Offering; Uplisting to the Nasdaq Capital Market and Reverse Stock Split

Oct 13, 2021, 12:25 PM EDT - 5 years ago

Bone Biologics Corp. Announces Pricing of $7.9 million Public Offering; Uplisting to the Nasdaq Capital Market and Reverse Stock Split

Kesiya Jun. 18 at 8:01 AM

$BBLG Buy now']

0 · Reply

Harold_the_Hedge Jun. 17 at 7:31 PM

$BBLG wen rs

0 · Reply

l33c14rky Jun. 17 at 10:11 AM

$BBLG round zwei 🥳

0 · Reply

ClassiTrader Jun. 17 at 8:40 AM

$BBLG 👀 1.60

0 · Reply

terrapin22 Jun. 17 at 6:21 AM

$BBLG still here waiting patiently

0 · Reply

tarzzanman Jun. 12 at 8:11 PM

$BBLG Trash 😂

0 · Reply

TheUnmaker Jun. 1 at 4:24 PM

$TNXP $HSCS $CCCC $BBLG

0 · Reply

TheUnmaker May. 29 at 11:45 AM

$TNXP Super strong this morning.. setting up for a run! $CCCC $SLS $QSI $BBLG

1 · Reply

TheUnmaker May. 28 at 9:35 PM

$TNXP Great hold on the 1H 55 EMA today.. strong support above the 15m 200 EMA as well. Shorts tried to kill it several times under $12.65 but they were very unsuccessful. We've all see how this eagle flies when her wings are clipped. Our time to shine is coming soon. $QSI $CCCC $SLS $BBLG

1 · Reply

TheUnmaker May. 28 at 5:11 PM

$TNXP We look ready for next leg up. $CCCC $SLS $BBLG $GALT

0 · Reply

TheUnmaker May. 28 at 4:52 PM

$TNXP Shorts are trapped here. They are trying to exit but buyers are strong! $CCCC $SLS $GALT $BBLG

0 · Reply

TheUnmaker May. 28 at 2:52 PM

$TNXP Dumb shorts! $CCCC $SLS $BBLG

0 · Reply

TheUnmaker May. 28 at 2:18 PM

$TNXP $SLS $CCCC $BBLG $GALT

0 · Reply

DARKP00L May. 19 at 12:08 PM

$BBLG 08:07 on May. 19 2026 Bone Biologics Announces Validated Shelf Life Extension Of Its rhNELL-1 Protein Product To 29 Months #tradeideas

1 · Reply

Jj1369 May. 15 at 5:40 PM

$BBLG moved above the 50day moving avg. on watch for a pump towards the 200day

0 · Reply

ZacksSCR May. 15 at 4:30 PM

$BBLG In Good Shape as Critical Tests Underway https://buff.ly/GAPY7Us

1 · Reply

WildFrontier May. 1 at 11:41 PM

0 · Reply

WildFrontier May. 1 at 11:38 PM

$BBLG bullish

0 · Reply

SuperGreenToday Apr. 30 at 3:46 AM

0 · Reply

Harold_the_Hedge Apr. 18 at 4:50 PM

$BBLG wen dilution and rs

0 · Reply

terrapin22 Apr. 17 at 7:02 PM

$BBLG jump

0 · Reply

terrapin22 Apr. 10 at 5:42 PM

0 · Reply